• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. Sep 1991; 50(9): 631–633.
PMCID: PMC1004507

Effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol.

Abstract

The effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol were investigated. Pyrazinamide decreased the mean (SEM) fractional clearance of oxypurinol from 19.2 (2.1) to 8.8 (1.5). Probenecid increased the fractional clearance of oxypurinol from 14.1 (3.5) to 24.8 (4.1). Benzbromarone increased the fractional clearance of oxypurinol from 15.6 (2.3) to 33.8 (2.8). These results suggest that oxypurinol may be secreted by 'an organic acid system' and that oxypurinol is reabsorbed at a putative postsecretory site of the renal tubules.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (474K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Appelbaum SJ, Mayersohn M, Dorr RT, Perrier D. Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration. Cancer Chemother Pharmacol. 1982;8(1):93–98. [PubMed]
  • Reiter S, Simmonds HA, Webster DR, Watson AR. On the metabolism of allopurinol. Formation of allopurinol-1-riboside in purine nucleoside phosphorylase deficiency. Biochem Pharmacol. 1983 Jul 15;32(14):2167–2174. [PubMed]
  • Hande K, Reed E, Chabner B. Allopurinol kinetics. Clin Pharmacol Ther. 1978 May;23(5):598–605. [PubMed]
  • Elion GB, Yü TF, Gutman AB, Hitchings GH. Renal clearance of oxipurinol, the chief metabolite of allopurinol. Am J Med. 1968 Jul;45(1):69–77. [PubMed]
  • Berlinger WG, Park GD, Spector R. The effect of dietary protein on the clearance of allopurinol and oxypurinol. N Engl J Med. 1985 Sep 26;313(13):771–776. [PubMed]
  • Colin JN, Farinotti R, Fredj G, Tod M, Clavel JP, Vignon E, Dietlin F. Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone. Eur J Clin Pharmacol. 1986;31(1):53–58. [PubMed]
  • de Vries A, Sperling O. Inborn hypouricemia due to isolated renal tubular defect. Biomedicine. 1979 Jun;30(2):75–80. [PubMed]
  • Steele TH, Boner G. Origins of the uricosuric response. J Clin Invest. 1973 Jun;52(6):1368–1375. [PMC free article] [PubMed]
  • Garcia Puig J, Mateos Antón F, Muñoz Sanz A, Gaspar G, Lesmes A, Ramos T, Ortiz Vázquez J. Renal handling of uric acid in normal subjects by means of the pyrazinamide and probenecid tests. Nephron. 1983;35(3):183–186. [PubMed]
  • Tofuku Y, Kuroda M, Takeda R. Hypouricemia due to renal urate wasting. Two types of tubular transport defect. Nephron. 1982;30(1):39–44. [PubMed]
  • Yamamoto T, Moriwaki Y, Takahashi S, Hada T, Higashino K. Separation of hypoxanthine and xanthine from pyrazinamide and its metabolites in plasma and urine by high-performance liquid chromatography. J Chromatogr. 1986 Oct 31;382:270–274. [PubMed]
  • Yamamoto T, Moriwaki Y, Takahashi S, Hada T, Higashino K. Rapid and simultaneous determination of pyrazinamide and its major metabolites in human plasma by high-performance liquid chromatography. J Chromatogr. 1987 Jan 23;413:342–346. [PubMed]
  • Breithaupt B, Tittel M. Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide. Eur J Clin Pharmacol. 1982;22(1):77–84. [PubMed]
  • Mertz DP, Eichhorn R. Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol? Klin Wochenschr. 1984 Dec 17;62(24):1170–1172. [PubMed]
  • Löffler W, Gröbner W, Zöllner N. Harnsäuresenkende Wirkung einer Kombination von Benzbromaron und Allopurinol - Untersuchungen unter standardisierten Ernährungsbedingungen. Arzneimittelforschung. 1983;33(12):1687–1691. [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...